Icon

EMFLAZA (nda208684)- (6MG,18MG,30MG,36MG)

DEFLAZACORT PTC THERAP
6MG,18MG,30MG,36MG
No Yes
Expired 2022-Feb-09
2024-Feb-09 None
None No
EMFLAZA is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
2 0 1
Total Other Developers 3
Drugs with Suitability No
6MG ** ** - - -
18MG ** ** - - -
30MG ** ** - - -
36MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.